🟢 Connect Biopharma is trading 12% up today in pre-market ahead of September Seabreeze STAT results

Connect Biopharma is trading 11.85% up now at $2.61, with the move appearing consistent with stronger pre-market sentiment.

• No new company-specific announcement was identified for August 27, 2026.
• The S&P 500 was up 0.52% and the Nasdaq Composite was up 1.17%.
• Investors may also be positioning ahead of September 2026 topline results from the Seabreeze STAT asthma and COPD studies, which the company expects to report in September 2026.